ASO Author Reflections: Commercialization of Adaptive Cell Therapy for Metastatic Melanoma

Ann Surg Oncol. 2023 Jan;30(1):602-603. doi: 10.1245/s10434-022-12588-9. Epub 2022 Sep 26.

Authors

Keshav Kooragayala¹, Johanna Lou¹, Young Ki Hong²

Affiliations

¹ Department of Surgery, Cooper University Hospital, Camden, NJ, USA.
² Department of Surgery, Cooper University Hospital, Camden, NJ, USA. Hong-young@cooperhealth.edu.

PMID: 36161376
DOI: 10.1245/s10434-022-12588-9

No abstract available

Publication types

Comment

MeSH terms

Cell- and Tissue-Based Therapy
Humans
Melanoma* / therapy
Neoplasms, Second Primary*